Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Chromatogr A ; 1629: 461480, 2020 Oct 11.
Artículo en Inglés | MEDLINE | ID: mdl-32827905

RESUMEN

Separation of antipsychotic drugs from whole blood and urine is of great importance for clinic and forensic laboratories. In this work, chlorprothixene, haloperidol and risperidone representing the first and second generations of antipsychotic drugs were studied. Among them, chlorprothixene and risperidone were investigated for the first time by electromembrane extraction (EME). After the screening, 2-nitrophenyl octyl ether (NPOE) was used as the supported liquid membrane (SLM). The EME performance for spiked water (pH 2), whole blood and urine was tested and optimized individually. Using NPOE and 60 V, efficient EME was achieved from urine and whole blood with trifluoroacetic acid as the acceptor solution. The equilibrium time required for EME was dependent on the sample matrices. The steady-state of EME was reached in 30 min and 20 min for whole blood and urine, respectively. At steady-state, the EME recoveries of the targets from different sample matrices were satisfactory, and were in the range of 74%-100%. The proposed EME approach combined with liquid chromatography-tandem mass spectrometry (LC-MS/MS) was evaluated using whole blood and urine. The obtained linearity was 1-200 ng mL-1, and the coefficient of determination (R2) was ≥ 0.9853 for haloperidol and ≥ 0.9936 for chlorprothixene and risperidone. The limit of detection (LOD) and accuracy for all the targets ranged from 0.2-0.6 ng mL-1 and 102%-110%, respectively, and the repeatability at low (1 ng mL-1), medium (10 ng mL-1) and high (200 ng mL-1) concentration was ≤ 12% (RSD). Finally, the validated approach was successfully used to determine chlorprothixene, risperidone and haloperidol in whole blood and urine from rats, which were treated with chlorprothixene, risperidone and haloperidol at low therapeutic dose, respectively.


Asunto(s)
Clorprotixeno/sangre , Clorprotixeno/orina , Electricidad , Haloperidol/sangre , Haloperidol/orina , Membranas Artificiales , Risperidona/sangre , Risperidona/orina , Ácidos/química , Animales , Antipsicóticos/sangre , Antipsicóticos/química , Antipsicóticos/orina , Líquidos Corporales , Clorprotixeno/química , Cromatografía Liquida , Haloperidol/química , Humanos , Masculino , Ratas Sprague-Dawley , Reproducibilidad de los Resultados , Risperidona/química , Solventes/química , Espectrometría de Masas en Tándem , Factores de Tiempo , Agua/química
2.
Sci Rep ; 8(1): 13763, 2018 09 13.
Artículo en Inglés | MEDLINE | ID: mdl-30213984

RESUMEN

Dysregulation of repressor-element 1 silencing transcription factor REST/NRSF is related to several neuropathies, including medulloblastoma, glioblastoma, Huntington's disease, and neuropathic pain. Inhibitors of the interaction between the N-terminal repressor domain of REST/NRSF and the PAH1 domain of its corepressor mSin3 may ameliorate such neuropathies. In-silico screening based on the complex structure of REST/NRSF and mSin3 PAH1 yielded 52 active compounds, including approved neuropathic drugs. We investigated their binding affinity to PAH1 by NMR, and their inhibitory activity toward medulloblastoma cell growth. Interestingly, three antidepressant and antipsychotic medicines, sertraline, chlorprothixene, and chlorpromazine, were found to strongly bind to PAH1. Multivariate analysis based on NMR chemical shift changes in PAH1 residues induced by ligand binding was used to identify compound characteristics associated with cell growth inhibition. Active compounds showed a new chemo-type for inhibitors of the REST/NRSF-mSin3 interaction, raising the possibility of new therapies for neuropathies caused by dysregulation of REST/NRSF.


Asunto(s)
Meduloblastoma/tratamiento farmacológico , Dominios Proteicos/efectos de los fármacos , Proteínas Represoras/química , Animales , Sitios de Unión/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Clorpromazina/química , Clorpromazina/farmacología , Clorprotixeno/química , Clorprotixeno/farmacología , Humanos , Meduloblastoma/genética , Meduloblastoma/patología , Ratones , Unión Proteica/genética , Dominios Proteicos/genética , Proteínas Represoras/antagonistas & inhibidores , Proteínas Represoras/genética , Proteínas de Transporte de Serotonina en la Membrana Plasmática/química , Proteínas de Transporte de Serotonina en la Membrana Plasmática/genética , Sertralina/química , Sertralina/farmacología
3.
J Med Chem ; 55(16): 7054-60, 2012 Aug 23.
Artículo en Inglés | MEDLINE | ID: mdl-22793499

RESUMEN

Reprofiling of existing drugs to treat conditions not originally targeted is an attractive means of addressing the problem of a decreasing stream of approved drugs. To determine if 3D shape similarity can be used to rationalize an otherwise serendipitous process, we employed 3D shape-based virtual screening to reprofile existing FDA-approved drugs. The study was conducted in two phases. First, multiple histamine H(1) receptor antagonists were identified to be used as query molecules, and these were compared to a database of approved drugs. Second, the hits were ranked according to 3D similarity and the top drugs evaluated in a cell-based assay. The virtual screening methodology proved highly successful, as 13 of 23 top drugs tested selectively inhibited histamine-induced calcium release with the best being chlorprothixene (IC(50) 1 nM). Finally, we confirmed that the drugs identified using the cell-based assay were all acting at the receptor level by conducting a radioligand-binding assay using rat membrane.


Asunto(s)
Bases de Datos de Compuestos Químicos , Antagonistas de los Receptores Histamínicos H1/química , Modelos Moleculares , Receptores Histamínicos H1/química , Animales , Antidepresivos/química , Antidepresivos/farmacología , Encéfalo/metabolismo , Calcio/metabolismo , Clorprotixeno/química , Clorprotixeno/farmacología , Células HeLa , Ensayos Analíticos de Alto Rendimiento , Histamina/farmacología , Antagonistas de los Receptores Histamínicos H1/farmacología , Humanos , Masculino , Conformación Molecular , Ensayo de Unión Radioligante , Ratas , Ratas Sprague-Dawley , Receptores Histamínicos H1/metabolismo , Relación Estructura-Actividad , Estados Unidos , United States Food and Drug Administration
4.
Photochem Photobiol ; 87(3): 611-7, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21294748

RESUMEN

2-chlorothioxanthone (CTX) is used as photoinitiator for the reticulation of synthetic resins and for the preparation of pharmaceuticals. It was previously determined that CTX is the primary photoproduct of z-chlorprothixene (CPTX) when irradiated at 313 nm and is formed in an autocatalyzed reaction through an energy-transfer mechanism (Piñero et al. [2009] Photochem. Photobiol., 85, 895-900). In this work, the photophysical properties of CTX were measured in acetonitrile/water solutions to determine if their magnitude can affect the side effects of CPTX. The results show that CTX has higher absorption coefficients in the visible region (400-420 nm) and higher triplet quantum yields than its parent compound. Similar to TX, both properties strongly depend on the solvent polarity/hydroxylicity. The quantum yield of the triplet intermediate is very close to the value of the phenothiazine triplets. The phenothiazines are the most phototoxic antidepressants. Therefore, given the appropriate microenvironment, the photosensitization side effects of CPTX can be intensified on the production of CTX.


Asunto(s)
Antipsicóticos/metabolismo , Clorprotixeno/metabolismo , Fármacos Fotosensibilizantes/metabolismo , Acetonitrilos/química , Antipsicóticos/efectos adversos , Antipsicóticos/química , Clorprotixeno/efectos adversos , Clorprotixeno/química , Transferencia de Energía , Humanos , Interacciones Hidrofóbicas e Hidrofílicas , Estructura Molecular , Procesos Fotoquímicos/efectos de la radiación , Fotólisis/efectos de la radiación , Fármacos Fotosensibilizantes/efectos adversos , Fármacos Fotosensibilizantes/química , Trastornos Psicóticos/tratamiento farmacológico , Solventes/química , Agua/química , Xantonas/química , Xantonas/metabolismo
5.
Photochem Photobiol ; 85(4): 895-900, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19708200

RESUMEN

Chlorprothixene (CPTX, Taractan) is a low potency antipsychotic mainly used for the treatment of psychotic disorders (e.g. schizophrenia) and acute mania occurring as part of bipolar disorders. As in the case of other numerous drugs used in the treatment of psychiatric disorders, CPTX presents geometric isomerism. Therefore, in vitro irradiation induces a rapid Z/E isomerization, which can affect its pharmacokinetic properties. This photoisomerization is not dependent on the oxygen concentration. The Z/E quantum yields determined for zCPTX in acetonitrile are 0.22 and 0.21 in anaerobic and aerobic environments, respectively. In the presence of water, both isomers decompose to produce 2-chlorothioxanthone (CTX) after prolonged irradiation. This process strongly depends on the water concentration and the irradiation time, i.e. it is autocatalyzed by the CTX through a triplet-energy transfer mechanism. The protonation state of the terminal amino group, on the other hand, has no effect on the isomerization process, but inhibits the formation of CTX. These results indicate that the phototoxicity of zCPTX is somehow affected by the formation of CTX.


Asunto(s)
Acetonitrilos/química , Antipsicóticos/química , Clorprotixeno/química , Fotoquímica
6.
Pak J Pharm Sci ; 19(2): 87-94, 2006 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-16751116

RESUMEN

Simple and sensitive UV-VIS spectrophotometric methods for the determination of chlorprothixene hydrochloride have been developed. One of them is based on the oxidation of chlorprothixene (CPT) by ammonium metavanadate with the formation of colourless product. The second method involves the formation of ion-pair between the drug under investigation and inorganic complexes of titanium (IV) thiocyanate followed by its extraction with mixture of butanol-chloroform (1:9, v/v). The optimum conditions for the oxidation of CPT or ion-pair formation are established. The studies are examined by UV-VIS, IR or NMR spectroscopy. The methods permit the determination of CPT over the concentration range of 2.5-25 mug/ml and 4-35 mug/ml using ammonium metavanadate or the titanium (IV) thiocyanate complex, respectively. The methods are rapid, highly reproducible and accurate with +/- 0.8%. The methods are applicable to the assay of the drug under investigation in different dosage forms and the results are in good agreement with those obtained by the official methods. Common excipients used as additives to active ingredient in pharmaceutical preparations do not interfere in the proposed methods. The extractive spectrophotometric method can be applied to the determination of chlorprothixene hydrochloride in tablets after solid phase extraction (SPE).


Asunto(s)
Antipsicóticos/análisis , Clorprotixeno/análisis , Espectrofotometría Infrarroja/métodos , Espectrofotometría Ultravioleta/métodos , Espectroscopía Infrarroja por Transformada de Fourier/métodos , Antipsicóticos/química , Clorprotixeno/química , Monitoreo de Drogas/métodos , Inyecciones , Espectroscopía de Resonancia Magnética , Oxidación-Reducción , Reproducibilidad de los Resultados , Comprimidos , Tiocianatos/química , Titanio/química , Vanadatos/química
7.
Artículo en Inglés | MEDLINE | ID: mdl-15683805

RESUMEN

Two methods for spectrophotometric determination of chlorprothixene and amitryptyline hydrochlorides were proposed. One of them is based on spectral analysis of their derivative spectra. The measurement of the value at 316.0 nm of first derivative was used for construction of calibration graph for chlorprothixene. The Beer law was obeyed in the concentration range 0.5-50.0 microg ml(-1). The amplitude of the second derivative at 261.4 nm was used for determination of amitryptyline in the range 0.5-75.0 microg ml(-1). The second proposed method is utilized the use of solid sorbent for simultaneous preconcentration and assay of studied compounds. For this purpose the filtration gel Sephadex G100 was applied. The elaborated solid-phase spectrophotometric method was used for determination of chlorprothixene at 268.0 nm in the range 2.5-75.0 microg ml(-1) and amitryptyline at 238.0 nm in the concentration range 10.0-75.0 microg ml(-1).


Asunto(s)
Amitriptilina/análisis , Amitriptilina/química , Clorprotixeno/análisis , Clorprotixeno/química , Concentración de Iones de Hidrógeno , Espectrofotometría Ultravioleta
8.
J Pharm Biomed Anal ; 29(3): 519-25, 2002 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-12062652

RESUMEN

A reversed-phase HPLC method with UV detection at 252 nm is presented for the simultaneous determination of some tricyclic antidepressants (amitriptyline, imipramine) and neuroleptics (chlorprothixene, thioridazine) in their quaternary mixtures. Sample analysis was performed on a bonded reversed phase C-18, 5 microm, 250 x 4.6 mm ID (Lichrospher 100RP-18) column using acetonitrile and 0.01 M aqueous solution of triethylamine (1:1) as the mobile phase at 0.9 ml/min. The pH was adjusted to 2.7 with concentrated phosphoric acid. The retention time was for imipramine, amitriptyline, chlorprothixene, and thioridazine 5.8, 6.5, 8.3, 10.8 min, respectively. The linearity was obeyed up to 15 ppm for imipramine and amitriptyline, 12 ppm for chlorprothixene and 10 ppm for thioridazine. The presented method also allows the determination of the mentioned drugs individually in their pharmaceutical preparations.


Asunto(s)
Antidepresivos Tricíclicos/análisis , Antipsicóticos/análisis , Amitriptilina/análisis , Amitriptilina/química , Antidepresivos Tricíclicos/química , Antipsicóticos/química , Clorprotixeno/análisis , Clorprotixeno/química , Cromatografía Líquida de Alta Presión , Combinación de Medicamentos , Imipramina/análisis , Imipramina/química , Control de Calidad , Tioridazina/análisis , Tioridazina/química
9.
J Chromatogr A ; 948(1-2): 309-19, 2002 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-12831207

RESUMEN

The chromatographic behavior of six calix[n]arene phases (n=4, 6, 8) and one calix[4]resorcinarene phase is described for the separation of cis- and trans-isomers of three thioxanthene (flupentixol, clopenthixol, chlorprothixene) and one benz[b,e]oxepin derivative (doxepin). The influences of two different organic modifiers (MeOH, MeCN) for the separation of the isomers on every column are described. Different selectivities of the stationary phases exist as a function of the ring size of the calixarenes and their substitution at the "upper rim" with p-tert.-butyl groups. Furthermore, the influence of free phenol groups on the resorcinarene phase is discussed. Relations between structural elements of the analytes and the retention behavior on the stationary phases are found. The selectivity of the calixarene and resorcinarene stationary phases is compared with a RP-C18 phase containing the same base silica. Advantages of the resorcinarene as well as of the calixarene columns exist for the separation of cis- and trans-isomers of three compounds dependent from the substitution in position 2 of the thioxanthenes, respectively the kind of the basic side chain of all substances.


Asunto(s)
Dibenzoxepinas/aislamiento & purificación , Sustancias Macromoleculares , Fenilalanina/análogos & derivados , Fenilalanina/química , Tioxantenos/aislamiento & purificación , Calixarenos , Clorprotixeno/química , Clorprotixeno/aislamiento & purificación , Cromatografía Líquida de Alta Presión , Clopentixol/química , Clopentixol/aislamiento & purificación , Dibenzoxepinas/química , Doxepina/química , Flupentixol/química , Flupentixol/aislamiento & purificación , Concentración de Iones de Hidrógeno , Indicadores y Reactivos , Isomerismo , Tioxantenos/química
10.
J Pharm Biomed Anal ; 14(4): 451-6, 1996 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-8729644

RESUMEN

The development of a reversed-phase liquid chromatographic method, using a mobile phase containing a mixture of anion and cation ion-pairing agents and a base-deactivated octyldecylsilyl column as stationary phase, is described for the control of all known impurities in (Z)-chlorprothixene hydrochloride (bulk drug). Validation of the method showed it to be reproducible, selective for both (Z) chlorprothixene hydrochloride and its E-isomer, accurate and linear over the concentration range of analysis with a limit of detection of 0.3 microgram ml-1.


Asunto(s)
Antipsicóticos/aislamiento & purificación , Clorprotixeno/aislamiento & purificación , Cromatografía Liquida/métodos , Antipsicóticos/química , Clorprotixeno/química , Conformación Molecular , Reproducibilidad de los Resultados
11.
J Pharm Sci ; 80(8): 735-40, 1991 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-1791531

RESUMEN

cis(Z)-Chlorprothixene has antidopaminergic potency, while trans(E)-chlorprothixene is virtually inactive. In order to reveal the structural features causing the difference in activity, the three-dimensional molecular and electronic structures of cis(Z)- and trans(E)-chlorprothixene were examined by computer graphics and molecular mechanical and quantum mechanical calculations. The internal molecular motions of the isomers were studied by molecular dynamics simulations in vacuo and in aqueous solution. The cis(Z)-isomer had lower potential molecular energy than the trans(E)-isomer, mainly due to electrostatic interactions within the side-chain and between the dimethylamino group and the chlorine atom. During molecular dynamics simulations in aqueous solution, the side-chain of the trans(E)-isomer stayed closer to the central S-C axis of the ring system than did the side-chain of the cis(Z)-isomer. The molecular electrostatic potentials were significantly lower in the vicinity of the chlorine atom in the trans(E)- than in the cis(Z)-isomer. Differences in molecular electrostatic potentials and in three-dimensional structure are suggested to be the main reasons for the difference in pharmacological activities of cis(Z)- and trans(E)-chlorprothixene.


Asunto(s)
Clorprotixeno/química , Gráficos por Computador , Modelos Químicos , Conformación Molecular , Estereoisomerismo , Relación Estructura-Actividad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA